Genetics and Evolution of Infectious Diseases

Dr. Michel Tibayrenc has worked on the evolution of infectious diseases for more than 45 years. He is a director of research emeritus at the French Institut de Recherche pour le Developpement (IRD) and the founder and editor-in-chief emeritus of the Elsevier journal Infection, Genetics and Evolution. From 1996-2021 he was the founder and principal organizer of Elsevier’s international MEEGID congress (Molecular Epidemiology and Evolutionary Genetics of Infectious Diseases). He has held professional appointments in France, Algeria, French Guiana, Bolivia, Thailand, and the United States; is the cofounder of the Bolivian Society of Human Genetics; and is a fellow of the American Association for the Advancement of Science.

1. Molecular epidemiology and species definition of pathogens2. Virus species3. Viral evolution4. Species concept in bacteria5. Population structure of pathogenic bacteria6. Evolution and pathogenesis of fungal organisms7. Clonal evolution8. Co-evolution between host and pathogen9. Elucidating human migration by means of their pathogens10. Phylogenetic analysis of pathogens11. Evolutionary effects of infectious diseases on humans12. General human population genetics, major genomic projects and their relevance for biomedical research13. Pathogen and vector sequencing projects14. Proteomics and Host–Pathogen Interactions: a bright future?15. Evolution of antibiotic resistance16. Mechanisms of antiviral resistance17. Evolution of resistance to insecticides in disease vectors18. Genetics of major insect vectors19. Modern morphometrics of medically important insects20. Multilocus sequence typing of pathogens21. Analysis of pathogen evolution using microarrays22. The bioinformatics revolution and infectious diseases23. Genomics of infectious diseases and private industry24. Pharmacogenetics: The à la carte medicine of tomorrow?25. Experimental recombination in trypanosomes: its relevance for formal genetics and epidemiology26. Population genetics of Plasmodium falciparum and the challenge of drug Resistance27. Molecular evolution of Trypanosoma cruzi: a new paradigmal model of basic science?28. Identification of Mycobacterium tuberculosis populations using microarrays: does it permit routine molecular epidemiology?29. The evolution and dynamics of methicillin-resistant Staphylococcusaureus: can it be controlled by public health measures?30. The origins of human immunodeficiency virus and implications for global Epidemics31. Evolution of SARS coronavirus and the relevance of modern molecular Epidemiology32. Ecology and evolution of avian influenza: the risk of a major pandemics